Shares of NeoGenomics Inc. (NEO) touched a 52-week high of $19.11 earlier this week, driven by the company's consistent revenue growth, enhanced operating efficiency, and stronger financial performance in the oncology testing services sector.
The company provides a wide range of oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians who specialize in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.